Pfizer Covid-19 vaccine gets emergency use authorisation in Bangladesh. The EUA was issued as per recommendation of the committee for the evaluation of drug, investigational drug, vaccine and medical device in case of public health emergency.
Bangladesh approves emergency use of Covid-19 Pfizer vaccine | Bangladesh Sangbad Sangstha (BSS) bssnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bssnews.net Daily Mail and Mail on Sunday newspapers.
See eTable 1 in Supplement 2 for definitions of each analysis population. Among those receiving aluminum hydroxide (alum) for the first dose, 5 participants received WIV04 (n = 2) and HB02 (n = 3) vaccines for the second dose and were not included in the safety analysis population of the alum-only group (13 458 – 5 = 13 453), but were included in the WIV04 and HB02 groups, respectively. Three participants who received WIV04 for the first dose and HB02 for the second dose and 3 participants who received HB02 for the first dose and WIV04 for the second dose were included in both groups (WIV04: 13 459 + 2 + 3 = 13 464; HB02: 13 465 + 3 + 3 = 13 471). To measure neutralization antibody levels, the first 900 participants from each study site were selected. There were 9 participants in the WIV04 group, 7 in the HB02 group, and 8 in alum-only group who had adverse events or serious adverse events (SAEs) after the first dose and did not receive the secon
Sinopharm vaccines arrive in Trinidad and Tobago newsday.co.tt - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.co.tt Daily Mail and Mail on Sunday newspapers.
Vaccination with WHO Approved Sinopharm COVID-19 Vaccine Begins on Friday 21 May, 2021
Port of Spain, 19 May 2021: Members of the public are advised that the national COVID-19 vaccination rollout will continue from
Friday 21 May, 2021.
50,000 eligible persons will be vaccinated with the World Health Organisation (WHO) approved Sinopharm COVID-19 vaccine, which was manufactured by the Beijing Institute of Biological Products Co. Limited. This vaccine is a 2 shot vaccine given 3 to 4 weeks apart. Globally, 65 million doses of the Sinopharm COVID-19 vaccine have already been administered through various emergency use programmes.
All persons who fall within the Phase 1 of the national COVID-19 Vaccine Deployment Plan, as indicated below, are eligible to receive the vaccine at this time: